ResMed Net Income Applicable To Common Shares from 2010 to 2026
| RME Stock | EUR 215.40 1.40 0.65% |
Net Income Applicable To Common Shares | First Reported 2017-03-31 | Previous Quarter 229.7 M | Current Value 229.7 M | Quarterly Volatility 72.3 M |
Check ResMed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ResMed's main balance sheet or income statement drivers, such as Interest Expense of 55.2 M, Selling General Administrative of 741.1 M or Total Revenue of 3.3 B, as well as many indicators such as . ResMed financial statements analysis is a perfect complement when working with ResMed Valuation or Volatility modules.
ResMed | Net Income Applicable To Common Shares |
The Net Income Applicable To Common Shares trend for ResMed Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether ResMed is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest ResMed's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of ResMed Inc over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. ResMed's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ResMed's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
ResMed Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 546,282,755 | |
| Geometric Mean | 497,989,902 | |
| Coefficient Of Variation | 46.29 | |
| Mean Deviation | 217,443,749 | |
| Median | 404,592,000 | |
| Standard Deviation | 252,868,424 | |
| Sample Variance | 63942.4T | |
| Range | 716.6M | |
| R-Value | 0.81 | |
| Mean Square Error | 23981.1T | |
| R-Squared | 0.65 | |
| Significance | 0.000096 | |
| Slope | 40,322,292 | |
| Total Sum of Squares | 1023079T |
ResMed Net Income Applicable To Common Shares History
About ResMed Financial Statements
ResMed stakeholders use historical fundamental indicators, such as ResMed's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although ResMed investors may analyze each financial statement separately, they are all interrelated. For example, changes in ResMed's assets and liabilities are reflected in the revenues and expenses on ResMed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ResMed Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 1 B | 537.5 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of ResMed Correlation against competitors. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.